Viatris Inc vs Consumer Discretionary Select Sector SPDR Fund — how do they compare? Viatris Inc trades at $17.58 (market cap $19.79B), while Consumer Discretionary Select Sector SPDR Fund trades at $114.87. The key difference: Viatris Inc pays a 2.83% dividend while Consumer Discretionary Select Sector SPDR Fund pays none, and Viatris Inc is trading nearer its 52-week high, Consumer Discretionary Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| VTRS | XLY | |
|---|---|---|
Market Cap | $19.79B | — |
Sector | Health | — |
52-Week High | $17.39 | $124.52 |
52-Week Low | $8.74 | $105.64 |
Enterprise Value | $32.00B | — |
Dividend Yield | 2.83% | — |
Trailing returns across standard periods
Latest headlines on both assets
Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).
Read more on VTRS →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes securities of companies from the following industries: retail; hotels, restaurants and leisure; textiles, apparel and luxury goods; household durables; automobiles; auto components; distributors; leisure products; and diversified consumer services. It is non-diversified.
Read more on XLY →